Kiltearn Partners LLP Has $46.76 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Kiltearn Partners LLP decreased its position in shares of CVS Health Co. (NYSE:CVS) by 8.1% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 791,668 shares of the pharmacy operator’s stock after selling 69,500 shares during the quarter. CVS Health makes up 5.7% of Kiltearn Partners LLP’s holdings, making the stock its 3rd largest holding. Kiltearn Partners LLP owned 0.06% of CVS Health worth $46,756,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Steph & Co. grew its holdings in CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 288 shares in the last quarter. Douglas Lane & Associates LLC grew its holdings in shares of CVS Health by 1.6% in the first quarter. Douglas Lane & Associates LLC now owns 1,084,256 shares of the pharmacy operator’s stock valued at $86,480,000 after purchasing an additional 16,840 shares in the last quarter. OLD Point Trust & Financial Services N A bought a new stake in CVS Health in the fourth quarter worth $151,000. State of Tennessee Treasury Department lifted its position in CVS Health by 10.4% during the fourth quarter. State of Tennessee Treasury Department now owns 624,817 shares of the pharmacy operator’s stock valued at $49,336,000 after purchasing an additional 58,836 shares during the last quarter. Finally, BOCHK Asset Management Ltd purchased a new position in shares of CVS Health in the 4th quarter worth $2,116,000. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on CVS. Robert W. Baird initiated coverage on shares of CVS Health in a report on Thursday, May 30th. They issued a “neutral” rating and a $61.00 price target for the company. Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a report on Monday, September 16th. Evercore ISI decreased their price target on CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a report on Thursday, August 8th. Baird R W upgraded CVS Health to a “hold” rating in a research report on Thursday, May 30th. Finally, Barclays cut their price objective on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 8th. Eleven investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $72.10.

CVS Health Trading Up 0.1 %

Shares of CVS Health stock opened at $57.57 on Tuesday. The company has a fifty day simple moving average of $58.28 and a 200-day simple moving average of $62.32. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The stock has a market cap of $72.27 billion, a price-to-earnings ratio of 10.12, a PEG ratio of 0.79 and a beta of 0.53.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping the consensus estimate of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.21 earnings per share. On average, equities analysts forecast that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be given a $0.665 dividend. The ex-dividend date is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.62%. CVS Health’s payout ratio is currently 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.